$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv

$hofv Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023065592 Filed on August 10, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$8.745M	$6.127M
YoY Change	0.93%	128.16%
Cost Of Revenue	$1.810M	$1.588M
YoY Change	0.02%	20.63%
Gross Profit	$6.930M	$4.540M
YoY Change	1.1%	231.51%
Gross Profit Margin	79.25%	74.09%
Selling, General & Admin	$12.41M	$10.69M
YoY Change	-10.36%	57.28%
% of Gross Profit	179.08%	235.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.560M	$3.373M
YoY Change	72.02%	-4.38%
% of Gross Profit	65.8%	74.3%
Operating Expenses	$18.78M	$15.65M
YoY Change	1.36%	28.74%
Operating Profit	-$10.04M	-$9.527M
YoY Change	1.74%	0.56%
Interest Expense	$6.027M	-$3.543M
YoY Change	260.8%	-484.54%
% of Operating Profit
Other Income/Expense, Net	-$6.126M	-$3.766M
YoY Change	460.55%	-1092.96%
Pretax Income	-$16.16M	-$13.29M
YoY Change	47.45%	46.16%
Income Tax
% Of Pretax Income
Net Earnings	-$16.16M	-$13.29M
YoY Change	47.49%	46.16%
Net Earnings / Revenue	-184.84%	-216.95%
Basic Earnings Per Share	-$2.89	-$2.39
Diluted Earnings Per Share	-$2.89	-$2.39
COMMON SHARES
Basic Shares Outstanding	5.672M shares	5.657M shares
Diluted Shares Outstanding	5.673M shares	5.661M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.300M	$9.307M
YoY Change	-72.98%	-12.32%
Cash & Equivalents	$11.76M	$9.307M
Short-Term Investments
Other Short-Term Assets	$3.500M	$3.338M
YoY Change	6.55%	29.71%
Inventory
Prepaid Expenses
Receivables	$3.700M	$2.641M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$11.50M	$15.29M
YoY Change	-49.49%	-4.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$368.0M	$370.9M
YoY Change	57.08%	97.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$5.800M	$18.11M
YoY Change
Other Assets	$7.500M	$7.544M
YoY Change	-55.06%	4.56%
Total Long-Term Assets	$435.6M	$435.8M
YoY Change	9.28%	20.45%
TOTAL ASSETS
Total Short-Term Assets	$11.50M	$15.29M
Total Long-Term Assets	$435.6M	$435.8M
Total Assets	$447.1M	$451.1M
YoY Change	6.1%	19.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.80M	$16.09M
YoY Change	-8.32%	-31.97%
Accrued Expenses	$3.400M	$3.422M
YoY Change	-0.26%	0.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$62.00M	$61.30M
YoY Change	321.17%
Total Short-Term Liabilities	$88.50M	$81.21M
YoY Change	94.01%	172.5%
LONG-TERM LIABILITIES
Long-Term Debt	$202.3M	$195.3M
YoY Change	23.6%	58.85%
Other Long-Term Liabilities	$12.10M	$14.83M
YoY Change	4524.16%	853.81%
Total Long-Term Liabilities	$214.4M	$210.1M
YoY Change	81835.58%	13412.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.50M	$81.21M
Total Long-Term Liabilities	$214.4M	$210.1M
Total Liabilities	$302.9M	$291.3M
YoY Change	40.14%	77.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$196.5M	-$180.1M
YoY Change	53.03%	53.55%
Common Stock	$567.00	$566.00
YoY Change	-95.32%	-95.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$145.1M	$160.8M
YoY Change
Total Liabilities & Shareholders Equity	$447.1M	$451.1M
YoY Change	6.1%	19.42%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$16.16M	-$13.29M
YoY Change	47.49%	46.16%
Depreciation, Depletion And Amortization	$4.560M	$3.373M
YoY Change	72.02%	-4.38%
Cash From Operating Activities	$70.00K	-$8.140M
YoY Change	-102.33%	-385.17%
INVESTING ACTIVITIES
Capital Expenditures	$18.15M	$9.998M
YoY Change	-147.97%	-149.29%
Acquisitions
YoY Change
Other Investing Activities	$12.55M	$20.21M
YoY Change
Cash From Investing Activities	-$5.600M	$10.21M
YoY Change	-85.2%	-150.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	430.0K	80.09K
YoY Change	-99.23%	-99.64%
NET CHANGE
Cash From Operating Activities	70.00K	-8.140M
Cash From Investing Activities	-5.600M	10.21M
Cash From Financing Activities	430.0K	80.09K
Net Change In Cash	-5.100M	2.150M
YoY Change	-134.52%	-57.65%
FREE CASH FLOW
Cash From Operating Activities	$70.00K	-$8.140M
Capital Expenditures	$18.15M	$9.998M
Free Cash Flow	-$18.08M	-$18.14M
YoY Change	-151.91%	-178.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q2	hofv	Convertible Preferred Stock Value ConvertiblePreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	hofv	Convertible Preferred Stock Value ConvertiblePreferredStockValue		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4964029	shares
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	HALL OF FAME RESORT & ENTERTAINMENT COMPANY
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3235695
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2014 Champions Gateway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Canton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44708
	dei	City Area Code CityAreaCode	(330)
	dei	Local Phone Number LocalPhoneNumber	754–3427
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5671676	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9307494	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26016547	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	7543499	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7499835	usd
CY2023Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	12359877	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	17033515	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5751000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4067754	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2640961	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1811143	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3338375	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3340342	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	370936371	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248826853	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7471745	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7562048	usd
CY2023Q2	hofv	Project Development Costs ProjectDevelopmentCosts	31779847	usd
CY2022Q4	hofv	Project Development Costs ProjectDevelopmentCosts	140138924	usd
CY2023Q2	us-gaap	Assets Assets	451129169	usd
CY2022Q4	us-gaap	Assets Assets	456296961	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	195270837	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	171315860	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16089531	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17575683	usd
CY2023Q2	hofv	Due To Affiliate1 DueToAffiliate1	399318	usd
CY2022Q4	hofv	Due To Affiliate1 DueToAffiliate1	855485	usd
CY2023Q2	hofv	Warrant Liability WarrantLiability	1372000	usd
CY2022Q4	hofv	Warrant Liability WarrantLiability	911000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	61299829	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60087907	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	240000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	200000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3422174	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3413210	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	13218842	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	10679704	usd
CY2023Q2	us-gaap	Liabilities Liabilities	291312531	usd
CY2022Q4	us-gaap	Liabilities Liabilities	265038849	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4917000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4917000	shares
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	2	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	2	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5667446	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5667446	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5604869	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5604869	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	566	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	560	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340814772	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	339038466	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180061757	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146898343	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	160753583	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	192140685	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	-936945	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-882573	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159816638	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	191258112	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	451129169	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	456296961	usd
CY2023Q2	hofv	Sponsorships Net Of Activation Costs SponsorshipsNetOfActivationCosts	691236	usd
CY2022Q2	hofv	Sponsorships Net Of Activation Costs SponsorshipsNetOfActivationCosts	452772	usd
	hofv	Sponsorships Net Of Activation Costs SponsorshipsNetOfActivationCosts	1364711	usd
	hofv	Sponsorships Net Of Activation Costs SponsorshipsNetOfActivationCosts	1272062	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3410010	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	668863	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4318322	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1006256	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	2026031	usd
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	1563900	usd
	us-gaap	Sublease Income SubleaseIncome	3564677	usd
	us-gaap	Sublease Income SubleaseIncome	2513741	usd
CY2023Q2	us-gaap	Revenues Revenues	6127277	usd
CY2022Q2	us-gaap	Revenues Revenues	2685535	usd
	us-gaap	Revenues Revenues	9247710	usd
	us-gaap	Revenues Revenues	4792059	usd
CY2023Q2	us-gaap	Other General Expense OtherGeneralExpense	10693853	usd
CY2022Q2	us-gaap	Other General Expense OtherGeneralExpense	7316113	usd
	us-gaap	Other General Expense OtherGeneralExpense	24367569	usd
	us-gaap	Other General Expense OtherGeneralExpense	14982722	usd
CY2023Q2	hofv	Hotel Operating Expenses HotelOperatingExpenses	1587620	usd
CY2022Q2	hofv	Hotel Operating Expenses HotelOperatingExpenses	1316150	usd
	hofv	Hotel Operating Expenses HotelOperatingExpenses	3046823	usd
	hofv	Hotel Operating Expenses HotelOperatingExpenses	2469262	usd
CY2023Q2	us-gaap	Depreciation Depreciation	3373076	usd
CY2022Q2	us-gaap	Depreciation Depreciation	3527581	usd
	us-gaap	Depreciation Depreciation	5926436	usd
	us-gaap	Depreciation Depreciation	6769866	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	15654549	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	12159844	usd
	us-gaap	Operating Expenses OperatingExpenses	33340828	usd
	us-gaap	Operating Expenses OperatingExpenses	24221850	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9527272	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9474309	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24093118	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19429791	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4404146	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	921392	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8036783	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2134933	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	882240	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1122324	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1738131	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2478298	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	223000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2423000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	461000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7173000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	60000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-40000	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1683246	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1683246	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-148472	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3766140	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	379284	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8592668	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2411297	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-13293412	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-9095025	usd
	us-gaap	Profit Loss ProfitLoss	-32685786	usd
	us-gaap	Profit Loss ProfitLoss	-17018494	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	266000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	266000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	532000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	532000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5795	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-158592	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-54372	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-235964	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13553617	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9202433	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-33163414	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-17314530	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.39
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5660385	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5183035	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5644822	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4964029	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	191258112	usd
CY2023Q1	hofv	Contribution From Shareholders ContributionFromShareholders	651034	usd
CY2023Q1	hofv	Sale Of Series B Preferred Stock And Warrant SaleOfSeriesBPreferredStockAndWarrant	-266000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-19392374	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	172250772	usd
CY2023Q2	hofv	Contribution From Shareholders ContributionFromShareholders	1086017	usd
CY2023Q2	hofv	Sale Of Shares Under Atm SaleOfSharesUnderATM	39261	usd
CY2023Q2	hofv	Sale Of Series B Preferred Stock And Warrant SaleOfSeriesBPreferredStockAndWarrant	-266000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-13293412	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159816638	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	204578244	usd
CY2022Q1	hofv	Contribution From Shareholders ContributionFromShareholders	1287695	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	28500	usd
CY2022Q1	hofv	Sale Of Shares Under Atm SaleOfSharesUnderATM	14234932	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	803061	usd
CY2022Q1	us-gaap	Financing Receivable Troubled Debt Restructuring Increase Decrease From Modification FinancingReceivableTroubledDebtRestructuringIncreaseDecreaseFromModification	1088515	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3736000	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	266000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-7923469	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	217567478	usd
CY2022Q2	hofv	Contribution From Shareholders ContributionFromShareholders	1254724	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	75419	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18709	usd
CY2022Q2	hofv	Sale Of Shares Under Atm SaleOfSharesUnderATM	3748282	usd
CY2022Q2	hofv	Sale Of Series B Preferred Stock And Warrant SaleOfSeriesBPreferredStockAndWarrant	-266000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-9095025	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	213303587	usd
	us-gaap	Profit Loss ProfitLoss	-32685786	usd
	us-gaap	Profit Loss ProfitLoss	-17018494	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5926436	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6769866	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1738131	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2478298	usd
	hofv	Amortization Of Financing Liability AmortizationOfFinancingLiability	3399422	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	1145000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	508610	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	2282040	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1681722	usd
	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	148472	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	40000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	461000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7173000	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1683246	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1737051	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2570919	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	258416	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	90876	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	829818	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	370525	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1143033	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-1430448	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1743958	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8196272	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-159149	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	9215	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-456167	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	1777542	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2539138	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	4830587	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19683133	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5422198	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	64606946	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	69815000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	19676877	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	40022805	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14468823	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40022805	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	22270339	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	20714311	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	783191	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3144677	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1552342	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	210032	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2187500	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	300000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	300000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	39261	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	17983214	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17486567	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35042816	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16665389	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	442209	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33516382	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17388040	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16850993	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17830249	usd
CY2023Q2	us-gaap	Cash Cash	9307494	usd
CY2022Q2	us-gaap	Cash Cash	10615810	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	7543499	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	7214439	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	16850993	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	17830249	usd
	us-gaap	Interest Paid Net InterestPaidNet	2644324	usd
	us-gaap	Interest Paid Net InterestPaidNet	3520404	usd
	hofv	Project Development Cost Acquired Through Accounts Payable And Accrued Expenses Net ProjectDevelopmentCostAcquiredThroughAccountsPayableAndAccruedExpensesNet	4539444	usd
	hofv	Amendment Of Series C Warrant Liability For Equity Classification AmendmentOfSeriesCWarrantLiabilityForEquityClassification	3336000	usd
	hofv	Amendment Of Series C And D Warrants AmendmentOfSeriesCAndDWarrants	400000	usd
	hofv	Initial Value Of Right Of Use Asset Upon Adoption Of Asc842 InitialValueOfRightOfUseAssetUponAdoptionOfASC842	7741955	usd
	hofv	Accrued Series B Preferred Stock Dividends AccruedSeriesBPreferredStockDividends	232000	usd
	hofv	Accrued Series B Preferred Stock Dividends AccruedSeriesBPreferredStockDividends	232000	usd
	hofv	Shares Issued In Connection With Amendment Of Notes Payable SharesIssuedInConnectionWithAmendmentOfNotesPayable	803061	usd
	hofv	Warrants Issued In Connection With Amendment Of Notes Payable WarrantsIssuedInConnectionWithAmendmentOfNotesPayable	1088515	usd
	hofv	Amounts Due To Affiliate Exchanged For Note Payable AmountsDueToAffiliateExchangedForNotePayable	850000	usd
	hofv	Shares Issued In Connection With Issuance Of Notes Payable SharesIssuedInConnectionWithIssuanceOfNotesPayable	75419	usd
	hofv	Warrants Issued In Connection With Issuance Of Notes Payable WarrantsIssuedInConnectionWithIssuanceOfNotesPayable	18709	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1: Organization, Nature of Business, and Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Organization and Nature of Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">Hall of Fame Resort & Entertainment Company, a Delaware corporation (together with its subsidiaries, unless the context indicates otherwise, the “Company” or “HOFRE”), was incorporated in Delaware as GPAQ Acquisition Holdings, Inc., a wholly owned subsidiary of our legal predecessor, Gordon Pointe Acquisition Corp. (“GPAQ”), a special purpose acquisition company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 1, 2020, the Company consummated a business combination with HOF Village, LLC, a Delaware limited liability company (“HOF Village”), pursuant to an Agreement and Plan of Merger dated September 16, 2019 (as amended on November 6, 2019, March 10, 2020 and May 22, 2020, the “Merger Agreement”), by and among the Company, GPAQ, GPAQ Acquiror Merger Sub, Inc., a Delaware corporation (“Acquiror Merger Sub”), GPAQ Company Merger Sub, LLC, a Delaware limited liability company (“Company Merger Sub”), HOF Village and HOF Village Newco, LLC, a Delaware limited liability company (“Newco”). The transactions contemplated by the Merger Agreement are referred to as the “Business Combination”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a resort and entertainment company leveraging the power and popularity of professional football and its legendary players in partnership with the National Football Museum, Inc., doing business as the Pro Football Hall of Fame (“PFHOF”). Headquartered in Canton, Ohio, the Company owns the Hall of Fame Village, a multi-use sports, entertainment, and media destination centered around the PFHOF’s campus. The Company is pursuing a differentiation strategy across three pillars, including destination-based assets, HOF Village Media Group, LLC (“Hall of Fame Village Media”), and gaming.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">The Company has entered into multiple agreements with PFHOF, and certain government entities, which outline the rights and obligations of each of the parties with regard to the property on which the Hall of Fame Village sits, portions of which are owned by the Company and portions of which are net leased to the Company by government and quasi-governmental entities (see Note 9 for additional information). Under these agreements, the PFHOF and the lessor entities are entitled to use portions of the Hall of Fame Village on a direct-cost basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Reverse Stock Split</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 27, 2022, the Company effectuated a reverse stock split of its shares of common stock at a ratio of 1-for-22. See Note 5, Stockholders’ Equity, for additional information. As a result, the number of shares and income (loss) per share disclosed throughout this Quarterly Report on Form 10-Q have been retrospectively adjusted to reflect the reverse stock split.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Liquidity and Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has sustained recurring losses through June 30, 2023 and the Company’s accumulated deficit was $180,061,757 as of such date. Since inception, the Company’s operations have been funded principally through the issuance of debt and equity. As of June 30, 2023, the Company had approximately $9.3 million of unrestricted cash, $7.5 million of restricted cash, and $12.4 million of liquid investments held to maturity, consisting of U.S. treasury securities. The Company has approximately $59.3 million of debt coming due through August 10, 2024. The Company may extend the maturity of up to $42.1 million principal of debt until March 31, 2025 for a fee of one percent of the outstanding principal. These factors raise substantial doubt about the Company’s ability to continue operations as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has entered into the following financing transactions. See Note 4 for more information on these transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2023, the Company sold 2,400 shares of the Company’s 7.00% Series A Cumulative Redeemable Preferred Stock, par value $0.0001 per share for an aggregate purchase price of $2,400,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2023, the Company received proceeds from the issuance by Stark County Port Authority of $18,100,000 principal amount Tax Increment Financing Revenue Bonds, Series 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 2, 2023, the Company issued 800 shares of the Company’s 7.00% Series A Cumulative Redeemable Preferred Stock at a price of $1,000 per share for an aggregate purchase price of $800,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects that it will need to raise additional financing to accomplish its development plan over the next several years. The Company is seeking to obtain additional funding through debt, construction lending, and equity financing. There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. If management is unable to execute its planned debt and equity financing initiatives, these conditions raise substantial doubt about the Company’s ability to continue as a going concern to sustain operations for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p>
CY2023Q2	us-gaap	Other Investments OtherInvestments	12400000	usd
CY2023Q2	us-gaap	Debt Securities DebtSecurities	59300000	usd
	us-gaap	Debt Securities Held To Maturity Purchase DebtSecuritiesHeldToMaturityPurchase	42100000	usd
	hofv	Debt Fee Percentage DebtFeePercentage	0.01	pure
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400	shares
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07	pure
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	0.0001
CY2023Q1	hofv	Aggregate Purchase Price AggregatePurchasePrice	2400000	usd
CY2023Q1	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	18100000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Reclassification</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain financial statement line items of the Company’s historical presentation have been reclassified to conform to the corresponding financial statement line items in 2023. These reclassifications have no material impact on the historical operating loss, net loss, total assets, total liabilities, or Stockholders’ equity previously reported.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates and assumptions for the Company relate to bad debt, depreciation, costs capitalized to project development costs, useful lives of long-lived assets, potential impairment, accounting for debt modifications and extinguishments, stock-based compensation, and fair value of financial instruments (including the fair value of the Company’s warrant liability). Management adjusts such estimates when facts and circumstances dictate. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	7543499	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7499835	usd
CY2023Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	12359877	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	17033515	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	5751000	usd
CY2022	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	4067754	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	7911440	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	5575700	usd
CY2023Q2	us-gaap	Film Costs FilmCosts	0	usd
	us-gaap	Payments For Film Costs PaymentsForFilmCosts	1305000	usd
	us-gaap	Payments For Film Costs PaymentsForFilmCosts	0	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1145000	usd
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
CY2023Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	1372000	usd
CY2022Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	911000	usd
CY2023Q2	us-gaap	Interest Rate Fair Value Hedge Liability At Fair Value InterestRateFairValueHedgeLiabilityAtFairValue	240000	usd
CY2022Q4	us-gaap	Interest Rate Fair Value Hedge Liability At Fair Value InterestRateFairValueHedgeLiabilityAtFairValue	200000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5751000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4067754	usd
CY2022Q4	hofv	Fair Value Warrant Liabilities FairValueWarrantLiabilities	911000	usd
	hofv	Change In Fair Value Outstanding ChangeInFairValueOutstanding	461000	usd
CY2023Q2	hofv	Fair Value Warrant Liabilities FairValueWarrantLiabilities	1372000	usd
	hofv	Total Potentially Dilutive Securities TotalPotentiallyDilutiveSecurities	6102409	shares
	hofv	Total Potentially Dilutive Securities TotalPotentiallyDilutiveSecurities	3702693	shares
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	438539943	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	310503989	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67603572	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61677136	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	370936371	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248826853	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31779847	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	140138924	usd
CY2023Q2	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	3373076	usd
CY2022Q2	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	3527581	usd
	hofv	Depreciation Expenses DepreciationExpenses	5926436	usd
	hofv	Depreciation Expenses DepreciationExpenses	6769866	usd
	us-gaap	Capitalized Costs Of Unproved Properties Excluded From Amortization CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization	19676877	usd
	us-gaap	Capitalized Costs Of Unproved Properties Excluded From Amortization CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization	40022805	usd
	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	127045169	usd
	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0	usd
CY2023Q2	us-gaap	Theatrical Film Costs Development TheatricalFilmCostsDevelopment	200000	usd
CY2022Q4	us-gaap	Theatrical Film Costs Development TheatricalFilmCostsDevelopment	982000	usd
CY2023Q2	hofv	Notes Payable Gross NotesPayableGross	208964760	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	13693923	usd
CY2023Q2	hofv	Notes Payables NotesPayables	195270837	usd
CY2022Q4	hofv	Notes Payable Gross NotesPayableGross	185195572	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	13879712	usd
CY2022Q4	hofv	Notes Payables NotesPayables	171315860	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-882240	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1122324	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1738131	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2478298	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	2282040	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	1681722	usd
	hofv	Redeemed Cash RedeemedCash	P5Y
	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P3Y
CY2023Q2	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2030-07-01
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	7400000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1360235	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	966062	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10030000	usd
	us-gaap	Sale Leaseback Transaction Imputed Interest Rate SaleLeasebackTransactionImputedInterestRate	0.052	pure
CY2022Q4	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	9700000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	18100000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6800000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1810000	usd
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-03-31
CY2023Q2	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	28000000	usd
CY2022Q4	us-gaap	Loans Held For Sale Maturity Date LoansHeldForSaleMaturityDate	2025-03-31
CY2022Q4	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.01	pure
	us-gaap	Stock Dividends Shares StockDividendsShares	90909	shares
	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.125	pure
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	12.77
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	12.77
	hofv	Agreement Agreement	0.1999	pure
	hofv	Note Payable Description NotePayableDescription	(i) issuance of shares of Common Stock in excess of the Nasdaq 19.99% Cap to IRG Affiliate Lenders with respect to transactions described in the IRG Letter Agreement; and (ii) the issuance to an entity wholly owned by a director of additional shares of Common Stock issuable upon the conversion of certain convertible debt and the exercise of certain warrants described in the IRG Letter Agreement.
CY2022Q2	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	5681	shares
CY2022Q2	hofv	Exercisable Term ExercisableTerm	P1Y
CY2022Q3	hofv	Lender Loan LenderLoan	10000000	usd
CY2022Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	10000000	usd
CY2022Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	0.04	pure
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	15961612	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	47393467	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	32220218	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3628667	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	7465957	usd
CY2023Q2	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	102294839	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	208964760	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	13693923	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	195270837	usd
	hofv	Aggregate Amounts AggregateAmounts	118344	usd
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	hofv	Number Of Shares NumberOfShares	275000	shares
	hofv	Shares Sold SharesSold	4878	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11088	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	8.16
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	11088	shares
	hofv	Weighted Average Grant Date Fair Value Vested WeightedAverageGrantDateFairValueVested	8.16
CY2023Q2	us-gaap	Shares Held In Employee Stock Option Plan Committed To Be Released SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased	6032	shares
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1343041	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1088959	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2003649	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	149.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M9D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2003649	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	149.09
	hofv	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Ending Balance SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance	P2Y4M9D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2003649	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	149.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y4M9D
	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	151.8
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	12.77
	hofv	Relative Rights Of Equity Percentage RelativeRightsOfEquityPercentage	0.07	pure
CY2023Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1000
CY2023Q1	hofv	Purchase Of Aggregate Amount PurchaseOfAggregateAmount	1600000	usd
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	800	shares
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1000
CY2023Q1	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	800000	usd
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	800	shares
CY2023Q2	hofv	Relative Rights Of Equity Percentage RelativeRightsOfEquityPercentage	0.07	pure
CY2023Q2	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	0.0001
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1000
CY2023Q2	hofv	Aggregate Purchase Price AggregatePurchasePrice	800000	usd
CY2022Q2	hofv	Issuance Of Restricted Stock Units Per Share IssuanceOfRestrictedStockUnitsPerShare	0.0001
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	110000	shares
CY2020Q3	hofv	Agreement Year AgreementYear	P1Y
CY2020Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	750000	usd
CY2020Q4	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	217000000	usd
CY2022Q2	hofv	Received Amount ReceivedAmount	4750000	usd
	us-gaap	Premiums Receivable Allowance For Doubtful Accounts Write Offs Against Allowance PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance	7187500	usd
CY2022	us-gaap	Premiums Receivable Allowance For Doubtful Accounts Write Offs Against Allowance PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance	4812500	usd
	us-gaap	Assets Under Management Average Balance AssetsUnderManagementAverageBalance	8697917	usd
CY2022	us-gaap	Assets Under Management Average Balance AssetsUnderManagementAverageBalance	6635417	usd
CY2023Q2	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	691236	usd
CY2022Q2	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	452772	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	1364711	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	1272062	usd
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.0275	pure
CY2019Q4	hofv	Agreement Percentage AgreementPercentage	0.02	pure
CY2019Q4	hofv	Base Management Fees BaseManagementFees	10000	usd
	hofv	Commencement Date CommencementDate	2024-10-22
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	55251	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	32844	usd
	us-gaap	Insurance Agency Management Fee InsuranceAgencyManagementFee	100751	usd
	us-gaap	Insurance Agency Management Fee InsuranceAgencyManagementFee	62844	usd
CY2021Q1	us-gaap	Escrow Deposit EscrowDeposit	2000000	usd
CY2021Q2	us-gaap	Retail Land Sales Installment Method Sales Value RetailLandSalesInstallmentMethodSalesValue	103095	usd
CY2022Q3	hofv	Agreement Term AgreementTerm	P10Y
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	262500	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3652119	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3511185	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	9276086	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	6867970	usd
	hofv	Deposits And Other Liabilities DepositsAndOtherLiabilities	290637	usd
CY2022	hofv	Deposits And Other Liabilities DepositsAndOtherLiabilities	300549	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	13218842	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	10679704	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8: Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the normal course of its business, the Company is subject to occasional legal proceedings and claims. The Company does not have any pending litigation that, separately or in the aggregate, would, in the opinion of management, have a material adverse effect on its results of operations, financial condition, or cash flows.</p>
CY2023Q2	hofv	Due To Related Parties Current1 DueToRelatedPartiesCurrent1	399318	usd
CY2022Q4	hofv	Due To Related Parties Current1 DueToRelatedPartiesCurrent1	855485	usd
CY2023Q2	hofv	Percentage Of Development Costs PercentageOfDevelopmentCosts	0.04	pure
	hofv	Annual Fees AnnualFees	600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	300000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6750000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9450000	usd
CY2023Q1	hofv	Proceeds From License Fees Paid ProceedsFromLicenseFeesPaid	0	usd
CY2022Q1	hofv	Proceeds From License Fees Paid ProceedsFromLicenseFeesPaid	318750	usd
	hofv	Proceeds From License Fees Paid ProceedsFromLicenseFeesPaid	300000	usd
	hofv	Proceeds From License Fees Paid ProceedsFromLicenseFeesPaid	318750	usd
CY2023Q2	us-gaap	Area Of Land AreaOfLand	1.64	sqm
	hofv	Hotel Construction Loan Description HotelConstructionLoanDescription	(a) a first priority perfected mortgage encumbering the Hotel Property; (b) a first priority perfected assignment of leases and rents with respect to the Hotel Property; (c) a first priority perfected assignment of all permits, licenses, entitlements, approvals, and contracts with respect to the Hotel Property; (d) UCC-1 financing statements (all personal property, fixture filing and accounts and reserves); (e) equity pledge; and (f) all other agreements and assurances customary in similar financings by IRGInc. The Hotel Construction Loan will bear interest at a variable rate per annum equal to the one-month Term SOFR plus 6%, subject to a SOFR floor equal to the greater of (i) 4% and (ii) prevailing SOFR at closing of the Hotel Construction Loan. Payments of interest only will be made during the initial two-year term, with a payments of principal and interest based on a 25-year amortization during the extension term, if applicable. Hotel will pay 1% of the Hotel Construction Loan amount as an origination fee, payable in full at closing. The Hotel Construction Loan definitive documentation will have representations, warranties and events of default usual and customary for such type of loan.
	us-gaap	Payments For Fees PaymentsForFees	4500000	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	90909	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	hofv	Percentage Of Bear Interest PercentageOfBearInterest	0.125	pure
	hofv	Accrued Interest Percentage AccruedInterestPercentage	0.08	pure
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12.77
	hofv	Membership Interest MembershipInterest	1	pure
	hofv	Contractual Percentage ContractualPercentage	0.25	pure
	hofv	Irg Letter Agreement Description IRGLetterAgreementDescription	IRGLLC and the Company agreed to comply with all federal and state securities laws and Nasdaq listing rules and to insert “blocker” provisions for the above-described re-pricing of the warrants and the conversion provisions, such that the total cumulative number of shares of Common Stock that may be issued to IRGLLC and its affiliated and related parties pursuant to the IRG Letter Agreement may not exceed the requirements of Nasdaq Listing Rule 5635(d) (“Nasdaq 19.99% Cap”), except that such limitation will not apply following approval of the Company’s stockholders. In addition, the provisions of the IRG Letter Agreement are limited by Nasdaq Listing Rule 5635(c).
	us-gaap	Related Party Transaction Effects Of Any Change In Method Of Establishing Terms RelatedPartyTransactionEffectsOfAnyChangeInMethodOfEstablishingTerms	(i) issuance of shares of Common Stock in excess of the Nasdaq 19.99% Cap to IRG Affiliate Lenders with respect to transactions described in the IRG Letter Agreement; and (ii) the issuance to an entity wholly owned by a director of additional shares of Common Stock issuable upon the conversion of certain convertible debt and the exercise of certain warrants described in the IRG Letter Agreement.
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	10%
CY2022	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	10%
	us-gaap	Operating Lease Cost OperatingLeaseCost	258416	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	258184	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	159149	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	158083	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P91Y2M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P92Y10D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	159149	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	311900	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	311900	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	311900	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	311900	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	41125000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42531749	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	39109575	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3422174	usd
CY2023Q2	us-gaap	Percentage Rent PercentageRent	82611	usd
CY2022Q2	us-gaap	Percentage Rent PercentageRent	6200	usd
	us-gaap	Percentage Rent PercentageRent	177151	usd
	us-gaap	Percentage Rent PercentageRent	14318	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	328369	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	645438	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	641542	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two And Three Years OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears	640962	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	619495	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2972365	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5848171	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P99Y
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	307125	usd
CY2022Q3	hofv	Annual Increases AnnualIncreases	0.02	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	4375000	usd
CY2023Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1025	pure
	us-gaap	Financing Interest Expense FinancingInterestExpense	61299829	usd
	us-gaap	Lease Cost LeaseCost	2201892776	usd
	hofv	Standardized Measure Of Discounted Futures Net Cash Flow Of Proved Oil And Gas Reserves Other StandardizedMeasureOfDiscountedFuturesNetCashFlowOfProvedOilAndGasReservesOther	2140592947	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	60087907	usd
CY2022	us-gaap	Lease Cost LeaseCost	2204080276	usd
CY2022	hofv	Standardized Measure Of Discounted Futures Net Cash Flow Of Proved Oil And Gas Reserves Other StandardizedMeasureOfDiscountedFuturesNetCashFlowOfProvedOilAndGasReservesOther	2143992369	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1832031	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	4672544	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	5865396	usd
CY2022	hofv	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	6005734	usd
CY2022Q4	hofv	Lessee Operating Lease Liability Payments Due Year Seven LesseeOperatingLeaseLiabilityPaymentsDueYearSeven	6149455	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	2177367616	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2201892776	usd
CY2022Q4	hofv	Imputed Interest ImputedInterest	-2140592947	usd
CY2022	hofv	Lessee Operating Lease Liability Payments Due Total LesseeOperatingLeaseLiabilityPaymentsDueTotal	61299829	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
CY2023Q1	hofv	Amount Paid For Fractional Shares AmountPaidForFractionalShares		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
CY2022Q1	hofv	Stock Issued During Period Value Of Preferred Stock Dividends StockIssuedDuringPeriodValueOfPreferredStockDividends		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
	hofv	Amortization Of Financing Liability AmortizationOfFinancingLiability		usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities		usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	hofv	Project Development Cost Acquired Through Accounts Payable And Accrued Expenses Net ProjectDevelopmentCostAcquiredThroughAccountsPayableAndAccruedExpensesNet		usd
	hofv	Amendment Of Series C Warrant Liability For Equity Classification AmendmentOfSeriesCWarrantLiabilityForEquityClassification		usd
	hofv	Amendment Of Series C And D Warrants AmendmentOfSeriesCAndDWarrants		usd
	hofv	Initial Value Of Right Of Use Asset Upon Adoption Of Asc842 InitialValueOfRightOfUseAssetUponAdoptionOfASC842		usd
	hofv	Shares Issued In Connection With Amendment Of Notes Payable SharesIssuedInConnectionWithAmendmentOfNotesPayable		usd
	hofv	Warrants Issued In Connection With Amendment Of Notes Payable WarrantsIssuedInConnectionWithAmendmentOfNotesPayable		usd
	hofv	Amounts Due To Affiliate Exchanged For Note Payable AmountsDueToAffiliateExchangedForNotePayable		usd
	hofv	Shares Issued In Connection With Issuance Of Notes Payable SharesIssuedInConnectionWithIssuanceOfNotesPayable		usd
	hofv	Warrants Issued In Connection With Issuance Of Notes Payable WarrantsIssuedInConnectionWithIssuanceOfNotesPayable		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares		shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001708176

Files In Submission

Name	View Source	Status
0001213900-23-065592-index-headers.html	Edgar Link	pending
0001213900-23-065592-index.html	Edgar Link	pending
0001213900-23-065592.txt	Edgar Link	pending
0001213900-23-065592-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_halloffame.htm	Edgar Link	pending
f10q0623ex31-2_halloffame.htm	Edgar Link	pending
f10q0623ex32_halloffame.htm	Edgar Link	pending
f10q0623_halloffame.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hofv-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hofv-20230630_cal.xml	Edgar Link	unprocessable
hofv-20230630_def.xml	Edgar Link	unprocessable
hofv-20230630_lab.xml	Edgar Link	unprocessable
hofv-20230630_pre.xml	Edgar Link	unprocessable
f10q0623_halloffame_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv

2023 Q3 Form 10-Q Financial Statement

#000121390023065592 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOFV Hall of Fame Resort & Entertainment Co Stock $hofv

2023 Q3 Form 10-Q Financial Statement

#000121390023065592 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv